1
|
Batarchuk V, Shepelytskyi Y, Grynko V, Kovacs AH, Hodgson A, Rodriguez K, Aldossary R, Talwar T, Hasselbrink C, Ruset IC, DeBoef B, Albert MS. Hyperpolarized Xenon-129 Chemical Exchange Saturation Transfer (HyperCEST) Molecular Imaging: Achievements and Future Challenges. Int J Mol Sci 2024; 25:1939. [PMID: 38339217 PMCID: PMC10856220 DOI: 10.3390/ijms25031939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2024] [Revised: 01/25/2024] [Accepted: 01/28/2024] [Indexed: 02/12/2024] Open
Abstract
Molecular magnetic resonance imaging (MRI) is an emerging field that is set to revolutionize our perspective of disease diagnosis, treatment efficacy monitoring, and precision medicine in full concordance with personalized medicine. A wide range of hyperpolarized (HP) 129Xe biosensors have been recently developed, demonstrating their potential applications in molecular settings, and achieving notable success within in vitro studies. The favorable nuclear magnetic resonance properties of 129Xe, coupled with its non-toxic nature, high solubility in biological tissues, and capacity to dissolve in blood and diffuse across membranes, highlight its superior role for applications in molecular MRI settings. The incorporation of reporters that combine signal enhancement from both hyperpolarized 129Xe and chemical exchange saturation transfer holds the potential to address the primary limitation of low sensitivity observed in conventional MRI. This review provides a summary of the various applications of HP 129Xe biosensors developed over the last decade, specifically highlighting their use in MRI. Moreover, this paper addresses the evolution of in vivo applications of HP 129Xe, discussing its potential transition into clinical settings.
Collapse
Affiliation(s)
- Viktoriia Batarchuk
- Chemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada; (V.B.)
- Thunder Bay Regional Health Research Institute, Thunder Bay, ON P7B 6V4, Canada
| | - Yurii Shepelytskyi
- Chemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada; (V.B.)
- Thunder Bay Regional Health Research Institute, Thunder Bay, ON P7B 6V4, Canada
| | - Vira Grynko
- Thunder Bay Regional Health Research Institute, Thunder Bay, ON P7B 6V4, Canada
- Chemistry and Materials Science Program, Lakehead University, Thunder Bay, ON P7B 5E1, Canada
| | - Antal Halen Kovacs
- Applied Life Science Program, Lakehead University, Thunder Bay, ON P7B 5E1, Canada
| | - Aaron Hodgson
- Physics Program, Lakehead University, Thunder Bay, ON P7B 5E1, Canada
| | - Karla Rodriguez
- Chemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada; (V.B.)
| | - Ruba Aldossary
- Thunder Bay Regional Health Research Institute, Thunder Bay, ON P7B 6V4, Canada
| | - Tanu Talwar
- Chemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada; (V.B.)
| | - Carson Hasselbrink
- Chemistry & Biochemistry Department, California Polytechnic State University, San Luis Obispo, CA 93407-005, USA
| | | | - Brenton DeBoef
- Department of Chemistry, University of Rhode Island, Kingston, RI 02881, USA
| | - Mitchell S. Albert
- Chemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada; (V.B.)
- Thunder Bay Regional Health Research Institute, Thunder Bay, ON P7B 6V4, Canada
- Faculty of Medical Sciences, Northern Ontario School of Medicine, Thunder Bay, ON P7B 5E1, Canada
| |
Collapse
|
2
|
Jost JO, Schröder L. Improving HyperCEST performance by favorable xenon exchange conditions in liposomal nanocarriers. NMR IN BIOMEDICINE 2023; 36:e4714. [PMID: 35181965 DOI: 10.1002/nbm.4714] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/12/2021] [Revised: 02/03/2022] [Accepted: 02/16/2022] [Indexed: 05/23/2023]
Abstract
MRI reporters that combine signal enhancement from saturation transfer with hyperpolarized 129 Xe show nanomolar detection sensitivity for in vitro studies. However, they need further improvement for accelerated CEST build-up that sufficiently dominates the intrinsic loss of hyperpolarization under in vivo conditions. This study introduces liposomes with a HyperCEST-active lipopeptide to enhance the efficiency of a well known Xe host, CrA-ma, with medium Xe exchange kinetics in aqueous environment, by two orders of magnitude. The depolarization time for constant saturation power but increasing saturation time is used as a comparative measure to rank different nanocarrier formulations. A variable cage load illustrates that the available CEST sites should be well distributed throughout the nanocarriers to avoid inefficiency from back exchange. For a liposome loading with only 2 mol% CrA-lipopeptide, the higher exchange kinetics allowed us to work even with 17-fold lower saturation power than for CrA-ma itself to achieve significant image contrast with 129 Xe. Overall, this study illustrates the wide parameter space that is now available when incorporating CrA-labelled lipopeptides into liposomal carriers.
Collapse
Affiliation(s)
- Jan Oliver Jost
- Translational Molecular Imaging, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
- Molecular Imaging, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
| | - Leif Schröder
- Translational Molecular Imaging, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
- Molecular Imaging, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany
| |
Collapse
|
3
|
Schmidt P, Vogel A, Schwarze B, Seufert F, Licha K, Wycisk V, Kilian W, Hildebrand PW, Mitschang L. Towards Probing Conformational States of Y2 Receptor Using Hyperpolarized 129Xe NMR. Molecules 2023; 28:molecules28031424. [PMID: 36771089 PMCID: PMC9919357 DOI: 10.3390/molecules28031424] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2022] [Revised: 01/20/2023] [Accepted: 01/30/2023] [Indexed: 02/05/2023] Open
Abstract
G protein-coupled receptors can adopt many different conformational states, each of them exhibiting different restraints towards downstream signaling pathways. One promising strategy to identify and quantify this conformational landscape is to introduce a cysteine at a receptor site sensitive to different states and label this cysteine with a probe for detection. Here, the application of NMR of hyperpolarized 129Xe for the detection of the conformational states of human neuropeptide Y2 receptor is introduced. The xenon trapping cage molecule cryptophane-A attached to a cysteine in extracellular loop 2 of the receptor facilitates chemical exchange saturation transfer experiments without and in the presence of native ligand neuropeptide Y. High-quality spectra indicative of structural states of the receptor-cage conjugate were obtained. Specifically, five signals could be assigned to the conjugate in the apo form. After the addition of NPY, one additional signal and subtle modifications in the persisting signals could be detected. The correlation of the spectroscopic signals and structural states was achieved with molecular dynamics simulations, suggesting frequent contact between the xenon trapping cage and the receptor surface but a preferred interaction with the bound ligand.
Collapse
Affiliation(s)
- Peter Schmidt
- Institute of Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Haertelstrasse 16-18, 04107 Leipzig, Germany
| | - Alexander Vogel
- Institute of Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Haertelstrasse 16-18, 04107 Leipzig, Germany
| | - Benedikt Schwarze
- Institute of Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Haertelstrasse 16-18, 04107 Leipzig, Germany
| | - Florian Seufert
- Institute of Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Haertelstrasse 16-18, 04107 Leipzig, Germany
| | - Kai Licha
- Institute of Chemistry and Biochemistry, Freie Universitaet Berlin, Takustrasse 3, 14195 Berlin, Germany
| | - Virginia Wycisk
- Institute of Chemistry and Biochemistry, Freie Universitaet Berlin, Takustrasse 3, 14195 Berlin, Germany
| | - Wolfgang Kilian
- Physikalisch-Technische Bundesanstalt Braunschweig und Berlin (PTB), Abbestrasse 2-12, 10587 Berlin, Germany
| | - Peter W. Hildebrand
- Institute of Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Haertelstrasse 16-18, 04107 Leipzig, Germany
| | - Lorenz Mitschang
- Physikalisch-Technische Bundesanstalt Braunschweig und Berlin (PTB), Abbestrasse 2-12, 10587 Berlin, Germany
- Correspondence:
| |
Collapse
|